chr12-112163079-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001388303.1(HECTD4):​c.13083G>A​(p.Pro4361Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00685 in 1,613,118 control chromosomes in the GnomAD database, including 61 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0053 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0070 ( 57 hom. )

Consequence

HECTD4
NM_001388303.1 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -9.36

Publications

2 publications found
Variant links:
Genes affected
HECTD4 (HGNC:26611): (HECT domain E3 ubiquitin protein ligase 4) Predicted to enable ubiquitin-protein transferase activity. Involved in glucose homeostasis and glucose metabolic process. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
MIR6861 (HGNC:50129): (microRNA 6861) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 12-112163079-C-T is Benign according to our data. Variant chr12-112163079-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 773266.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-9.36 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0053 (805/151894) while in subpopulation NFE AF = 0.00717 (487/67940). AF 95% confidence interval is 0.00664. There are 4 homozygotes in GnomAd4. There are 453 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001388303.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HECTD4
NM_001388303.1
MANE Select
c.13083G>Ap.Pro4361Pro
synonymous
Exon 75 of 76NP_001375232.1A0A804HJX8
HECTD4
NM_001109662.4
c.13113G>Ap.Pro4371Pro
synonymous
Exon 75 of 76NP_001103132.4
MIR6861
NR_106921.1
n.*179G>A
downstream_gene
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HECTD4
ENST00000682272.1
MANE Select
c.13083G>Ap.Pro4361Pro
synonymous
Exon 75 of 76ENSP00000507687.1A0A804HJX8
HECTD4
ENST00000377560.9
TSL:5
c.13077G>Ap.Pro4359Pro
synonymous
Exon 75 of 76ENSP00000366783.7J3KPF0
HECTD4
ENST00000550722.5
TSL:5
c.12681G>Ap.Pro4227Pro
synonymous
Exon 75 of 76ENSP00000449784.2F8VWT9

Frequencies

GnomAD3 genomes
AF:
0.00531
AC:
806
AN:
151776
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00148
Gnomad AMI
AF:
0.00220
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.000970
Gnomad SAS
AF:
0.00560
Gnomad FIN
AF:
0.0177
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00717
Gnomad OTH
AF:
0.00479
GnomAD2 exomes
AF:
0.00623
AC:
1548
AN:
248352
AF XY:
0.00665
show subpopulations
Gnomad AFR exome
AF:
0.00129
Gnomad AMR exome
AF:
0.00102
Gnomad ASJ exome
AF:
0.00170
Gnomad EAS exome
AF:
0.000723
Gnomad FIN exome
AF:
0.0149
Gnomad NFE exome
AF:
0.00857
Gnomad OTH exome
AF:
0.00565
GnomAD4 exome
AF:
0.00701
AC:
10242
AN:
1461224
Hom.:
57
Cov.:
32
AF XY:
0.00706
AC XY:
5130
AN XY:
726890
show subpopulations
African (AFR)
AF:
0.00122
AC:
41
AN:
33476
American (AMR)
AF:
0.00101
AC:
45
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.00119
AC:
31
AN:
26078
East Asian (EAS)
AF:
0.000302
AC:
12
AN:
39696
South Asian (SAS)
AF:
0.00413
AC:
356
AN:
86220
European-Finnish (FIN)
AF:
0.0152
AC:
811
AN:
53362
Middle Eastern (MID)
AF:
0.00816
AC:
47
AN:
5762
European-Non Finnish (NFE)
AF:
0.00774
AC:
8600
AN:
1111588
Other (OTH)
AF:
0.00495
AC:
299
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
549
1099
1648
2198
2747
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
320
640
960
1280
1600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00530
AC:
805
AN:
151894
Hom.:
4
Cov.:
32
AF XY:
0.00610
AC XY:
453
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.00147
AC:
61
AN:
41406
American (AMR)
AF:
0.00144
AC:
22
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3468
East Asian (EAS)
AF:
0.000778
AC:
4
AN:
5144
South Asian (SAS)
AF:
0.00561
AC:
27
AN:
4814
European-Finnish (FIN)
AF:
0.0177
AC:
187
AN:
10542
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00717
AC:
487
AN:
67940
Other (OTH)
AF:
0.00474
AC:
10
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
42
84
126
168
210
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00601
Hom.:
4
Bravo
AF:
0.00385
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.00731
EpiControl
AF:
0.00730

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.58
DANN
Benign
0.61
PhyloP100
-9.4
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs183882784; hg19: chr12-112600883; API